Stephen A. Harrison
0000-0001-8285-2204
Publication & Citation Trends
Publications
767 total
Plain language summary about GLP-1 treatments in people with metabolic dysfunction-associated steatotic liver disease
Cited by 0
Semantic Scholar
TERN-501 monotherapy and combination therapy with TERN-101 in metabolic dysfunction-associated steatohepatitis: the randomized phase 2a DUET trial
Cited by 11
Semantic Scholar
Clinical validation of an AI-based pathology tool for scoring of metabolic dysfunction-associated steatohepatitis OA
Cited by 34
Semantic Scholar
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis. OA
Cited by 1,085
Semantic Scholar
FGF21 Agonists: An Emerging Therapeutic for Metabolic Dysfunction-Associated Steatohepatitis and Beyond.
Cited by 110
Semantic Scholar
Integrating liver endpoints in clinical trials of cardiovascular and kidney disease
Cited by 27
Semantic Scholar
Liver Biopsy Evaluation in MASH Drug Development: Think Thrice, Act Wise.
Cited by 21
Semantic Scholar
Enhancing Histology Detection in MASH Cirrhosis for Artificial Intelligence Pathology Platform by Expert Pathologist Training OA
Cited by 2
Semantic Scholar
Research Topics
Liver Disease Diagnosis and Treatment
(460)
Diet, Metabolism, and Disease
(95)
Liver Disease and Transplantation
(94)
Liver Diseases and Immunity
(93)
Hepatitis C virus research
(86)
Affiliations
Linköping University
United States Army Medical Command
Northwestern University
Roche (Switzerland)
Unifor